Here you will find a profile of each of our Centre researchers detailing their research interests, key publications and contact details.
-
close
Alexandrea MacPherson
PREDICT-MesoUniversity of Glasgow -
closeInstitution: University of Glasgow Area of interest:
Focusing on the molecular events that induce haemopoietic stem cells (HSCs) to commit and differentiate towards the B and T lymphocyte lineages.
Teams: Leukaemias Team Publications:PreviousAlison Michie
LeukaemiaUniversity of Glasgow -
closeInstitution: University of Glasgow Area of interest: Teams: Publications:Previous
Alistair Boyer
Chemical BiologyUniversity of Glasgow -
closeInstitution: Glasgow Precision Oncology Lab, University of Glasgow Area of interest:
Research goals are to improve outcomes for individuals with pancreatic cancer through the development of early detection and novel therapeutic strategies based on molecular phenotyping and the delineation and implementation of biomarkers that facilitate clinical decision-making.
CENTRE LEAD
Teams: PREDICT-Meso Pancreatic Cancer Team Publications:PreviousAndrew Biankin
Pancreatic Cancer, PREDICT-MesoGlasgow Precision Oncology Lab, University of Glasgow -
closeInstitution: University of Glasgow Area of interest:
Research in the Sutherland group focuses on the development and understanding of new organic reactions with particular emphasis on using transition metal catalysis to create new chiral molecules.
Teams: Publications:PreviousAndrew Sutherland
Chemical BiologyUniversity of Glasgow -
closeInstitution: University of Glasgow Area of interest:
Glioblastoma is the commonest and most aggressive primary brain tumour and is often refractory to conventional cancer treatments. The ultimate aim of our research group is to improve outcomes for patients with these tumours by overcoming their inherent resistance to radiotherapy and chemotherapy.
Teams: RadNet Brain Tumours Team Publications:PreviousAnthony Chalmers
Brain Tumours, RadNetUniversity of Glasgow -
closeInstitution: University of Glasgow Area of interest: Teams: Colorectal Cancer Team Publications:Previous
Antonia Roseweir
Colorectal CancerUniversity of Glasgow -
closeInstitution: University of Glasgow Area of interest: Teams: Colorectal Cancer Team Publications:Previous
Campbell Roxburgh
Colorectal CancerUniversity of Glasgow -
closeInstitution: University of Glasgow Area of interest: Teams: Publications:Previous
Chiara Braconi
University of Glasgow -
closeInstitution: University of Glasgow Area of interest:
Investigating mechanisms of central nervous system disease in childhood acute lymphoblastic leukaemia (ALL) and ways to reduce treatment related toxicity in this condition.
Teams: Leukaemias Team Publications:PreviousChris Halsey
LeukaemiaUniversity of Glasgow -
close
Claire Paterson
RadNetBeatson West of Scotland Cancer Centre -
closeInstitution: NHS Greater Glasgow and Clyde Area of interest: Teams: PREDICT-Meso Publications:Previous
Clare Orange
PREDICT-MesoNHS Greater Glasgow and Clyde -
closeInstitution: NHS Greater Glasgow and Clyde Area of interest: Teams: Colorectal Cancer Team Pancreatic Cancer Team Publications:Previous
Colin Steele
Colorectal Cancer, Pancreatic CancerNHS Greater Glasgow and Clyde -
closeInstitution: NHS Greater Glasgow and Clyde Area of interest:
Intrathoracic malignancies including lung cancer and mesothelioma.
Teams: PREDICT-Meso Publications:PreviousCraig Dick
Lung cancer, PREDICT-MesoNHS Greater Glasgow and Clyde -
closeInstitution: CRUK Beatson Institute, University of Glasgow Area of interest: Teams: PREDICT-Meso Publications:Previous
Crispin Miller
PREDICT-MesoCRUK Beatson Institute, University of Glasgow -
closeInstitution: CRUK Beatson Institute, University of Glasgow Area of interest:
The oncogene-induced alterations selectively required by cancer cells to maintain viability.
Teams: PREDICT-Meso Pancreatic Cancer Team Publications:PreviousDaniel Murphy
Pancreatic Cancer, PREDICT-MesoCRUK Beatson Institute, University of Glasgow -
closeInstitution: CRUK Beatson Institute, University of Glasgow Area of interest:
Control of cell polarity in prostate cancer, part the role played by ARF GTPases and the cell surface protein Podocalyxin.
Teams: Prostate Cancer Team Publications:PreviousDave Bryant
Prostate CancerCRUK Beatson Institute, University of Glasgow -
closeInstitution: Glasgow Precision Oncology Lab, University of Glasgow Area of interest:
The development and implementation of stratified medicine through molecular phenotyping using both tissue- and genomic-based assays.
Teams: PREDICT-Meso Colorectal Cancer Team Pancreatic Cancer Team Publications:PreviousDavid Chang
Colorectal Cancer, Pancreatic Cancer, PREDICT-MesoGlasgow Precision Oncology Lab, University of Glasgow -
closeInstitution: University of Glasgow Area of interest: Teams: Publications:Previous
David France
Chemical BiologyUniversity of Glasgow -
close
David Irvine
LeukaemiaUniversity of Glasgow -
close
David Lewis
RadNetCRUK Beatson Institute -
closeInstitution: University of Glasgow Area of interest: Teams: Colorectal Cancer Team Publications:Previous
David Mansouri
Colorectal CancerUniversity of Glasgow -
closeInstitution: University of Glasgow Area of interest: Teams: Colorectal Cancer Team Publications:Previous
Donald McMillan
Colorectal CancerUniversity of Glasgow -
closeInstitution: University of Glasgow Area of interest: Teams: Breast Cancer Team Publications:Previous
Ewan Cameron
Breast CancerUniversity of Glasgow -
close
Fiona Thomson
RadNetUniversity of Glasgow -
closeInstitution: CRUK Beatson Institute Area of interest: Teams: RadNet PREDICT-Meso Publications:Previous
Gareth Inman
PREDICT-Meso, RadNetCRUK Beatson Institute -
closeInstitution: CRUK Beatson Institute Area of interest:
Preclinical PET/MRI imaging of cancer using specific probes that allows non-invasive longitudinal assessment of biological processes, such as tumour metabolism, cell proliferation, angiogenesis, hypoxia and receptor dynamics.
Teams: Publications:PreviousGaurav Malviya
CRUK Beatson Institute -
closeInstitution: University of Glasgow Area of interest:
Studying quiescent leukaemic stem cells in order to find ways to overcome resistance to chemotherapy in CML.
Teams: Leukaemias Team Publications:PreviousHeather Jørgensen
LeukaemiaUniversity of Glasgow -
closeInstitution: University of Glasgow Area of interest:
Study of the developmental pathways involved in normal and aberrant haemopoietic stem cells.
Teams: Leukaemias Team Publications:PreviousHelen Wheadon
LeukaemiaUniversity of Glasgow -
closeInstitution: CRUK Beatson Institute Area of interest:
The significance of the FGF and ERK5 signalling pathways in prostate cancer.
Teams: Prostate Cancer Team Publications:PreviousHing Leung
Prostate CancerCRUK Beatson Institute -
closeInstitution: CRUK Beatson Institute, University of Glasgow Area of interest:
Rab-coupling protein (RCP)-mediated receptor trafficking in breast cancer progression.
Teams: Breast Cancer Team Publications:PreviousIain MacPherson
Breast CancerCRUK Beatson Institute, University of Glasgow -
closeInstitution: CRUK Beatson Institute, University of Glasgow Area of interest:
Understanding how aberrant signalling drives both bladder and prostate carcinogenesis.
Teams: Prostate Cancer Team Publications:PreviousImran Ahmad
Prostate CancerCRUK Beatson Institute, University of Glasgow -
closeInstitution: University of Glasgow Area of interest: Teams: Colorectal Cancer Team Publications:Previous
James Park
Colorectal CancerUniversity of Glasgow -
closeInstitution: University of Glasgow Area of interest: Teams: Colorectal Cancer Team Publications:Previous
Janet Graham
Colorectal CancerUniversity of Glasgow -
closeInstitution: CRUK Beatson Institute, University of Glasgow Area of interest:
Using transgenic models of pancreatic cancer to determine how potential anti-cancer agents might best be evaluated in subsequent clinical trials.
CENTRE LEAD
Teams: Pancreatic Cancer Team Publications:PreviousJeff Evans
Pancreatic CancerCRUK Beatson Institute, University of Glasgow -
closeInstitution: CRUK Beatson Institute Area of interest:
Our research focuses mainly on:
Teams: Pancreatic Cancer Team Publications:
(a) Investigating the importance of mutations found in human pancreatic tumours using mouse models.
(b) Profiling different genetic subsets of pancreatic cancer to better understand the disease and identify specific targets for therapy.
(c) Preclinical trials of targeted therapies in clinically and genetically relevant pancreatic cancer mouse models.PreviousJen Morton
Pancreatic CancerCRUK Beatson Institute -
closeInstitution: CRUK Beatson Institute Area of interest:
The contribution of Rab-regulated integrin trafficking to cancer cell migration.
Teams: Breast Cancer Team Publications:PreviousJim Norman
Breast CancerCRUK Beatson Institute -
closeInstitution: University of Glasgow Area of interest:
Mammary gland development of the mouse as a model system for mammary neoplasia.
Teams: Breast Cancer Team Publications:PreviousJoanna Morris
Breast CancerUniversity of Glasgow -
closeInstitution: University of Glasgow Area of interest:
Investigation of signal transduction mechanisms associated with the development and progression of breast, colorectal, renal and prostate cancer.
Teams: Colorectal Cancer Team Prostate Cancer Team Breast Cancer Team Publications:PreviousJoanne Edwards
Breast Cancer, Colorectal Cancer, Prostate CancerUniversity of Glasgow -
closeInstitution: University of Glasgow Area of interest:
The main research interest of the Prunet group is the synthesis of biologically active natural products, especially anticancer agents, and the development of new synthetic methodologies in organic chemistry. We are also working on new methods for conjugating small-molecule drugs with biocompatible polymers for drug delivery.
Teams: Publications:List of publications (ResearcherID)
PreviousJoëlle Prunet
Chemical BiologyUniversity of Glasgow -
closeInstitution: University of Glasgow Area of interest: Teams: Publications:Previous
John Le Quesne
Lung cancerUniversity of Glasgow -
closeInstitution: University of Glasgow Area of interest: Teams: Colorectal Cancer Team Publications:Previous
Julia Cordero
Colorectal CancerUniversity of Glasgow -
closeInstitution: CRUK Beatson Institute Area of interest: Teams: Publications:
See Profile for Recent Publications
PreviousJustin Bower
Chemical BiologyCRUK Beatson Institute -
closeInstitution: CRUK Beatson Institute Area of interest:
The role of RUNX2 in metastatic breast and prostate cancer.
Teams: RadNet Breast Cancer Team Publications:See Profile for Recent Publications
PreviousKaren Blyth
Breast Cancer, RadNetCRUK Beatson Institute -
closeInstitution: University of Glasgow Area of interest:
The study of normal and malignant haematopoiesis.
Teams: Leukaemias Team Publications:PreviousKaren Keeshan
LeukaemiaUniversity of Glasgow -
closeInstitution: University of Glasgow Area of interest:
Pathology of gastro-intestinal and liver disease, especially cancer.
Teams: Pancreatic Cancer Team Publications:PreviousKarin Oien
Pancreatic CancerUniversity of Glasgow -
closeInstitution: NHS Greater Glasgow and Clyde, Queen Elizbeth University Hospital, University of Glasgow Area of interest:
Translational research focused on novel blood, imaging and physical biomarkers of pleural malignancy, particularly Mesothelioma, and Lung Cancer. Our imaging research is centred around Magnetic Resonance Imaging. Clinical trial portfolio includes studies in diagnostics, imaging, intra-pleural therapy and pleurodesis. Additional areas of interest include Interventional Pulmonology.
Teams: PREDICT-Meso Publications:Link to PubMed
PreviousKevin Blyth
Lung cancer, PREDICT-MesoNHS Greater Glasgow and Clyde, Queen Elizbeth University Hospital, University of Glasgow -
close
Laura Alexander
PREDICT-MesoCRUK Clinical Trials Unit -
closeInstitution: CRUK Beatson Institute Area of interest:
The control and mechanisms of actin assembly in various normal and cancer cells.
Teams: Pancreatic Cancer Team Breast Cancer Team Publications:See Profile for Recent Publications
PreviousLaura Machesky
Breast Cancer, Pancreatic CancerCRUK Beatson Institute -
closeInstitution: University of Glasgow Area of interest:
The abnormalities of stem cell self-renewal and bone marrow microenvironment that develop in myeloid leukaemias.
Teams: Leukaemias Team Publications:PreviousMhairi Copland
LeukaemiaUniversity of Glasgow -
closeInstitution: University of Glasgow Area of interest:
Upper GI surgery and pancreaticobiliary disease.
Teams: Pancreatic Cancer Team Publications:PreviousNigel Jamieson
Pancreatic CancerUniversity of Glasgow -
closeInstitution: CRUK Beatson Institute Area of interest:
Use of novel inducible models of intestinal tumourigenesis to study the functions of specific tumour suppressor genes.
CENTRE LEAD
Teams: RadNet Colorectal Cancer Team Prostate Cancer Team Pancreatic Cancer Team Publications:See Profile for Recent Publications
PreviousOwen Sansom
Colorectal Cancer, Pancreatic Cancer, Prostate Cancer, RadNetCRUK Beatson Institute -
closeInstitution: University of Glasgow Area of interest: Teams: Colorectal Cancer Team Publications:Previous
Paul Horgan
Colorectal CancerUniversity of Glasgow -
closeInstitution: University of Glasgow Area of interest: Teams: Colorectal Cancer Team Publications:
Link to Enlighten, University of Glasgow
PreviousPeter Bailey
Colorectal CancerUniversity of Glasgow -
closeInstitution: University of Glasgow Area of interest:
We develop mitochondria-targeted probes for understanding the role of this metabolic and signalling hub in cancer. The probes include sensors, fluorophores and photo-activated and ROS-activated prodrugs.
Teams: Publications:PreviousRichard Hartley
Chemical BiologyUniversity of Glasgow -
closeInstitution: CRUK Clinical Trials Unit, University of Glasgow Area of interest:
Optimising the use of chemotherapy in prostate cancer.
Teams: PREDICT-Meso Prostate Cancer Team Publications:PreviousRob Jones
Clinical Trials, PREDICT-Meso, Prostate CancerCRUK Clinical Trials Unit, University of Glasgow -
closeInstitution: University of Glasgow Area of interest:
Research in the Liskamp group is directed towards the creation of molecules that can be used to obtain insights into diseases such as infections and cancer, which may also lead to new approaches for their treatment.
Teams: Publications:PreviousRob Liskamp
Chemical BiologyUniversity of Glasgow -
closeInstitution: University of Glasgow Area of interest: Teams: Publications:Previous
Ross Cagan
University of Glasgow -
closeInstitution: University of Glasgow Area of interest:
The development and utility of novel PET/SPECT radiopharmaceuticals in both clinical and preclinical research studies.
Teams: Publications:PreviousSally Pimlott
University of Glasgow -
closeInstitution: CRUK Beatson Institute Area of interest:
Using state-of-the-art mass spectrometry and quantitative proteomics to study the complex molecular mechanisms regulating endothelial cells during angiogenesis.
Teams: Breast Cancer Team Publications:See Profile for Recent Publications
PreviousSara Zanivan
Breast CancerCRUK Beatson Institute -
closeInstitution: Beatson West of Scotland Cancer Centre, University of Glasgow Area of interest: Teams: RadNet Publications:Previous
Sean O’Cathail
RadNetBeatson West of Scotland Cancer Centre, University of Glasgow -
closeInstitution: CRUK Beatson Institute, University of Glasgow Area of interest: Teams: PREDICT-Meso Colorectal Cancer Team Publications:
See Profile for Recent Publications
PreviousSeth Coffelt
Colorectal Cancer, PREDICT-MesoCRUK Beatson Institute, University of Glasgow -
closeInstitution: University of Glasgow Area of interest: Teams: Publications:Previous
Stephen Clark
Chemical BiologyUniversity of Glasgow -
closeInstitution: University of Glasgow Area of interest:
The molecular and cellular changes that occur during mammary gland development and how these are deregulated in breast cancer.
Teams: Breast Cancer Team Publications:PreviousTorsten Stein
Breast CancerUniversity of Glasgow -
closeInstitution: University of Glasgow Area of interest:
The role of autophagy in disease persistence and drug resistance in CML.
Teams: Leukaemias Team Publications:PreviousVignir Helgason
LeukaemiaUniversity of Glasgow -
close
Xu Huang
LeukaemiaUniversity of Glasgow